Growth hormone use in children with short stature - Tips from Other Journals

bourgeoning speed correlates with growth hormone secretion. It has been proposeed that children with short stature and inadequate spontaneous germination hormone secretion may represent a subset of children diagnosed with neurosecretory dysfunction who would benefit from sprouting hormone supplementation. Measurements of shooting hormone secretion may help identify children who will benefit from product hormone therapy. Zadik and associates evaluated the germination response to growth hormone treatment and the growing deceleration after discontinuation of therapy.

The subject of attention included 150 children with short stature who had a normal birth weight and normal peak expansion hormone levels after clonidine stimulation. vegetation hormone concentrations were determined, and the children were divided into a treatment dispose and a nontreatment group. The treatment clump was randomly assigned to receive either 005 or 01 IU for kg per day of expansion hormone. Patients were followed each three months for an average of eight years during the prepubertal period.

The children who were initially raise to have low growth hormone concentrations were significantly taller forward follow-up than those who had normal germination hormone concentrations. Following discontinuation of bourgeoning hormone supplementation, a marked deceleration of produce occurred in all children, unless both groups regained pretreatment germination velocity after 12 months.

Use of subnormal spontaneous secretion of sprouting hormone as a marker of potential germination with treatment has been controversial. Findings of this subject of attention demonstrate significantly better height obtained with product hormone supplementation in the cluster with subnormal levels of growing hormone when compared with the normal cluster However, it appeared that in children with short stature and normal spontaneous secretion of product hormone, supplementation did not suppres the hypothalamic neurosecretory mechanisms, since all children regained normal product velocity.

The authors conclud that height attained in extension hormone-deficient children following supplementation with sprouting hormone was significantly better than height attained in children with normal spontaneous secretion of vegetation hormone.

Zadik Z, et al. produce of short children during and after discontinuation of sprouting hormone therapy. J Clin Endocrinol Metab 1996;81:3668-70

COPYRIGHT 1997 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group